Cerebral endothelial function determined by Cerebrovascular reactivity to L-arginine

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Pretnar Oblak, Janja ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; VASODILATOR AGENT;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BLOOD VESSEL FUNCTION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR REACTIVITY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; LACUNAR STROKE; MIGRAINE; NERVOUS SYSTEM PARAMETERS; NONHUMAN; REVIEW; SYSTEMATIC REVIEW; TRANSCRANIAL DOPPLER; VASODILATATION; ADRENERGIC SYSTEM; ANIMAL; BIOLOGICAL MODEL; BRAIN ARTERY; DRUG EFFECTS; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ARGININE; BLOOD FLOW VELOCITY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, CARDIOVASCULAR; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 84900018787     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/601515     Document Type: Review

References (58)

1. Aird W. C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Research 2007 100 2 158 173 2-s2.0-33846798106 10.1161/01.RES.0000255691.76142.4a
2. Jørgensen L. G., Transcranial Doppler ultrasound for cerebral perfusion. Acta physiologica Scandinavica. Supplementum 1995 625 1 44
3. Micieli G., Bosone D., Costa A., Cavallini A., Marcheselli S., Pompeo F., Nappi G., Opposite effects of L-arginine and nitroglycerin on cerebral blood velocity: nitric oxide precursors and cerebral blood velocity. Journal of the Neurological Sciences 1997 150 1 71 75 2-s2.0-0030788932 10.1016/S0022-510X(97) 05380-X
4. 2 and L-Arginine in patients with severe internal carotid artery stenosis; pre- and post-surgical evaluation with transcranial Doppler. Journal of the Neurological Sciences 1999 163 2 153 158 2-s2.0-0033084218 10.1016/S0022-510X(99)00027-1
5. Okamoto M., Etani H., Yagita Y., Kinoshita N., Nukada T.-A., Diminished reserve for cerebral vasomotor response to L-arginine in the elderly: evaluation by transcranial Doppler sonography. Gerontology 2001 47 3 131 135 2-s2.0-0035023559 10.1159/000052786
6. Zvan B., Zaletel M., Pogacnik T., Kiauta T., Testing of cerebral endothelium function with L-arginine after stroke. International Angiology 2002 21 3 256 259 2-s2.0-0036760365
7. Zimmermann C., Wimmer M., Haberl R. L., L-arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovascular Diseases 2004 17 2-3 128 133 2-s2.0-1942531435 10.1159/000075781
8. Strandgaard S., Paulson O. B., Regulation of cerebral blood flow in health and disease. Journal of Cardiovascular Pharmacology 1992 19 supplement 6 S89 S93 2-s2.0-0026660726
9. Traystman R. J., Welch K. M. A., Caplan R. L., Reis J. D., Regulation of cerebral blood flow by carbon dioxide. Primer on Cerebrovascular Diseases 1997 New York, NY, USA Academic Press 55 58
10. Moncada S., Higgs A., The L-arginine-nitric oxide pathway. New England Journal of Medicine 1993 329 27 2002 2012 2-s2.0-0027752805 10.1056/ NEJM199312303292706
11. Sadoshima S., Yoshida F., Ibayashi S., Shiokawa O., Fujishima M., Upper limit of cerebral autoregulation during development of hypertension in spontaneously hypertensive rats-effect of sympathetic denervation. Stroke 1985 16 3 477 481 2-s2.0-0021848950
12. Serrador J. M., Sorond F. A., Vyas M., Gagnon M., Iloputaife I. D., Lipsitz L. A., Cerebral pressure-flow relations in hypertensive elderly humans: transfer gain in different frequency domains. Journal of Applied Physiology 2005 98 1 151 159 2-s2.0-11144318012 10.1152/japplphysiol.00471.2004
13. Silvestrini M., Vernieri F., Pasqualetti P., Matteis M., Passarelli F., Troisi E., Caltagirone C., Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. Journal of the American Medical Association 2000 283 16 2122 2127 2-s2.0-0034716822
14. 2 vasoreactivity: association with endothelial dysfunction. The American Journal of Physiology-Heart and Circulatory Physiology 2006 291 4 H1856 H1861 2-s2.0-33749353561 10.1152/ajpheart.00014.2006
15. Aaslid R., Markwalder T. M., Nornes H., Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. Journal of Neurosurgery 1982 57 6 769 774 2-s2.0-0020394689
16. Report of the American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee Assessment: Transcranial Doppler. Neurology 1990 40 4 680 681 10.1212/WNL.40.4.680
17. Samdani A. F., Dawson T. M., Dawson V. L., Nitric oxide synthase in models of focal ischemia. Stroke 1997 28 6 1283 1288 2-s2.0-0030988138
18. Njemanze P. C., Cerebral lateralization in linguistic and nonlinguistic perception: analysis of cognitive styles in the auditory modality. Brain and Language 1991 41 3 367 380 2-s2.0-0025999491 10.1016/0093-934X(91)90161-S
19. Morikawa E., Rosenblatt S., Moskowitz M. A., L-Arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia. British Journal of Pharmacology 1992 107 4 905 907 2-s2.0-0026460295
20. Sun D., Messina E. J., Koller A., Wolin M. S., Kaley G., Endothelium-dependent dilation to L-arginine in isolated rat skeletal muscle arterioles. The American Journal of Physiology-Heart and Circulatory Physiology 1992 262 4 H1211 H1216 2-s2.0-0026724802
21. Bode-Böger S. M., Böger R. H., Creutzig A., L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clinical Science 1994 87 303 310
22. Adams M. R., McCredie R., Jessup W., Robinson J., Sullivan D., Celermajer D. S., Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997 129 2 261 269 2-s2.0-0031002483 10.1016/S0021-9150(96)06044-3
23. Khosh F., Khosh M., Natural approach to hypertension. Alternative Medicine Review 2001 6 6 590 600 2-s2.0-0035674582
24. Maxwell A. J., Anderson B., Zapien M. P., Cooke J. P., Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity. Cardiovascular Drugs and Therapy 2000 14 3 309 316 2-s2.0-0033922798 10.1023/A:1007886725480
25. Fideleff H. L., Frigeri A. E., Sobrado P. G., Llano M. N., Ruibal G. F., Boquete H. R., Reproducibility and variability of the arginine test in normal adults. Comparison between sexes. Medicina (B Aires) 1999 59 3 249 253
26. Andresen J., Shafi N. I., Bryan R. M. Jr., Endothelial influences on cerebrovascular tone. Journal of Applied Physiology 2006 100 1 318 327 2-s2.0-33644820886 10.1152/japplphysiol.00937.2005
27. Wu G., Meininger C. J., Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. The American Journal of Physiology-Heart and Circulatory Physiology 1995 269 4 H1312 H1318 2-s2.0-0028846979
28. Kaposzta Z., Baskerville P. A., Madge D., Fraser S., Martin J. F., Markus H. S., L-Arginine and S-nitrosoglutathione reduce embolization in humans. Circulation 2001 103 19 2371 2375 2-s2.0-0035873973
29. Rosenblum W. I., Nishimura H., Nelson G. H., Endothelium-dependent L-Arg- and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. The American Journal of Physiology-Heart and Circulatory Physiology 1990 259 5 H1396 H1401 2-s2.0-0025051531
30. Tousoulis D., Davies G. J., Tentolouris C., Crake T., Katsimaglis G., Stefanadis C., Toutouzas P., Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries. The American Journal of Cardiology 1998 82 9 1110 1113 2-s2.0-0031762098 10.1016/S0002-9149(98)00563-3
31. Raitakari O. T., Celermajer D. S., Flow-mediated dilatation. British Journal of Clinical Pharmacology 2000 50 5 397 404 2-s2.0-0033737304 10.1046/j.1365-2125.2000.00277.x
32. Perko D., Pretnar-Oblak J., Šabovič M., Žvan B., Zaletel M., Differences between cerebrovascular reactivity to L-arginine in the anterior and posterior cerebral circulation. Cerebrovascular Diseases 2011 31 4 358 364 2-s2.0-78651593163 10.1159/000322562
33. Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., Lloyd J. K., Deanfield J. E., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet 1992 340 8828 1111 1115 2-s2.0-0026478022 10.1016/0140-6736(92)93147-F
34. Pretnar-Oblak J., Zaletel M., Zvan B., Sabovic M., Pogacnik T., Cerebrovascular reactivity to L-arginine in patients with lacunar infarctions. Cerebrovascular Diseases 2006 21 3 180 186 2-s2.0-33645795997 10.1159/000090530
35. Kozera G. M., Wolnik B., Kunicka K. B., Szczyrba S., Wojczal J., Schminke U., Nyka W. M., Bieniaszewski L., Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes. Diabetes Care 2009 32 5 878 882 2-s2.0-65949091166 10.2337/dc08-1805
36. Kozera G. M., Dubaniewicz M., Zdrojewski T., Madej-Dmochowska A., Mielczarek M., Wojczal J., Chwojnicki K., Swierblewska E., Schminke U., Wyrzykowski B., Nyka W. M., Cerebral vasomotor reactivity and extent of white matter lesions in middle-aged men with arterial hypertension: a pilot study. The American Journal of Hypertension 2010 23 11 1198 1203 2-s2.0-77958085960 10.1038/ajh.2010.152
37. Niwa M., Inao S., Takayasu M., Kawai T., Kajita Y., Nihashi T., Kabeya R., Sugimoto T., Yoshida J., Asano T., Tada T., Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurologia Medico-Chirurgica 2001 41 2 63 73 2-s2.0-0035086889 10.2176/nmc.41.63
38. Armengou A., Hurtado O., Leira R., Obón M., Pascual C., Moro M. A., Lizasoain I., Castillo J., Dávalos A., L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study. Journal of Cerebral Blood Flow and Metabolism 2003 23 8 978 984 2-s2.0-0041568551
39. Wei H. M., Chi O. Z., Liu X., Sinha A. K., Weiss H. R., Nitric oxide synthase inhibition alters cerebral blood flow and oxygen balance in focal cerebral ischemia in rats. Stroke 1994 25 2 445 450 2-s2.0-23444441150
40. Margaill I., Allix M., Boulu R. G., Plotkine M., Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. British Journal of Pharmacology 1997 120 1 160 163 2-s2.0-0031034916 10.1038/sj.bjp.0700889
41. Willmot M., Gibson C., Gray L., Murphy S., Bath P., Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radical Biology and Medicine 2005 39 3 412 425 2-s2.0-21444442708 10.1016/j.freeradbiomed.2005.03.028
42. Pretnar-Oblak J., Sabovic M., Sebestjen M., Pogacnik T., Zaletel M., Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006 37 10 2540 2545 2-s2.0-33749028158 10.1161/01.STR.0000239659.99112.fb
43. Mitchell G. F., Parise H., Vita J. A., Larson M. G., Warner E., Keaney J. F. Jr., Keyes M. J., Levy D., Vasan R. S., Benjamin E. J., Local shear stress and brachial artery flow-mediated dilation: the Framingham heart study. Hypertension 2004 44 2 134 139 2-s2.0-3543022093 10.1161/01.HYP.0000137305. 77635.68
44. Veltkamp R., Rajapakse N., Robins G., Puskar M., Shimizu K., Busija D., Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 2002 33 11 2704 2710 2-s2.0-0036842344 10.1161/01.STR.0000033132.85123.6A
45. Iadecola C., Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neurosciences 1997 20 3 132 139 2-s2.0-0031020172 10.1016/S0166-2236(96)10074-6
46. Endres M., Statins and stroke. Journal of Cerebral Blood Flow and Metabolism 2005 25 9 1093 1110 2-s2.0-24944503596 10.1038/sj.jcbfm.9600116
47. Vaughan C. J., Prevention of stroke and dementia with statins: effects beyond lipid lowering. The American Journal of Cardiology 2003 91 4 23B 29B 2-s2.0-0037456569 10.1016/S0002-9149(02)03270-8
48. Amarenco P., Lavallée P., Touboul P.-J., Statins and stroke prevention. Cerebrovascular Diseases 2004 17 1 81 88 2-s2.0-0348048848 10.1159/000074799
49. The European Stroke Organisation (ESO), Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovascular Diseases 2008 25 457 507 10.1159/000131083
50. Perko D., Pretnar-Oblak J., Šabovič M., Žvan B., Zaletel M., Cerebrovascular reactivity to l-arginine in the anterior and posterior cerebral circulation in migraine patients. Acta Neurologica Scandinavica 2011 124 4 269 274 2-s2.0-80053085122 10.1111/j.1600-0404.2010. 01468.x
51. Saka B., Oflaz H., Erten N., Bahat G., Dursun M., Pamukcu B., Mercanoglu F., Meric M., Karan M. A., Non-invasive evaluation of endothelial function in hypertensive elderly patients. Archives of Gerontology and Geriatrics 2005 40 1 61 71 2-s2.0-8644270585 10.1016/j.archger.2004.05.008
52. Chan S. Y., Mancini G. B. J., Kuramoto L., Schulzer M., Frohlich J., Ignaszewski A., The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. Journal of the American College of Cardiology 2003 42 6 1037 1043 2-s2.0-0042234294 10.1016/S0735-1097(03)00927-6
53. Pretnar-Oblak J., Sabovic M., Vidmar G., Zaletel M., Evaluation of L-arginine reactivity in comparison with flow-mediated dilatation and intima-media thickness. Ultrasound in Medicine and Biology 2007 33 10 1546 1551 2-s2.0-34548856787 10.1016/j.ultrasmedbio.2007.04.011
54. Furumoto T., Saito N., Dong J., Mikami T., Fujii S., Kitabatake A., Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertension Research 2002 25 3 475 480 2-s2.0-0035991469 10.1291/hypres.25.475
55. Witte D. R., Broekmans W. M. R., Kardinaal A. F. M., Klöpping- Ketelaars I. A. A., Van Poppel G., Bots M. L., Kluft C., Princen J. M. G., Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis 2003 170 1 147 153 2-s2.0-0042261658 10.1016/S0021- 9150(03)00253-3
56. Agewall S., Henareh L., Kublickiene K., Endothelial function in conduit and resistance arteries in men with coronary disease. Atherosclerosis 2006 184 1 130 136 2-s2.0-28344447856 10.1016/j.atherosclerosis.2005.03.025
57. Palmer R. M. J., Ashton D. S., Moncada S., Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988 333 6174 664 666 2-s2.0-0023912670
58. Pretnar-Oblak J., Sebestjen M., Sabovic M., Statin treatment improves cerebral more than systemic endothelial dysfunction in patients with arterial hypertension. The American Journal of Hypertension 2008 21 6 674 678 2-s2.0-44349111370 10.1038/ajh.2008.153